SG Americas Securities’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-48,365
Closed -$658K 2690
2025
Q1
$658K Buy
48,365
+37,362
+340% +$508K ﹤0.01% 1392
2024
Q4
$224K Buy
11,003
+6,195
+129% +$126K ﹤0.01% 1806
2024
Q3
$140K Sell
4,808
-9,000
-65% -$262K ﹤0.01% 2484
2024
Q2
$321K Buy
13,808
+6,667
+93% +$155K ﹤0.01% 1739
2024
Q1
$147K Buy
+7,141
New +$147K ﹤0.01% 1982
2023
Q4
Sell
-35,800
Closed -$739K 2816
2023
Q3
$739K Buy
35,800
+26,326
+278% +$543K 0.01% 1387
2023
Q2
$280K Sell
9,474
-27,817
-75% -$822K ﹤0.01% 1434
2023
Q1
$859K Buy
37,291
+32,745
+720% +$754K 0.01% 1139
2022
Q4
$126K Sell
4,546
-8,305
-65% -$230K ﹤0.01% 2318
2022
Q3
$394K Sell
12,851
-26,465
-67% -$811K ﹤0.01% 1556
2022
Q2
$1.16M Buy
39,316
+30,336
+338% +$893K 0.01% 1034
2022
Q1
$289K Sell
8,980
-23,822
-73% -$767K ﹤0.01% 1983
2021
Q4
$1.46M Buy
32,802
+1,907
+6% +$85.1K 0.01% 1237
2021
Q3
$1.56M Buy
30,895
+13,625
+79% +$688K 0.01% 1370
2021
Q2
$1.36M Sell
17,270
-9,908
-36% -$777K 0.01% 1238
2021
Q1
$1.55M Buy
27,178
+1,559
+6% +$89K 0.01% 1102
2020
Q4
$2.15M Sell
25,619
-57,528
-69% -$4.82M 0.01% 924
2020
Q3
$2.98M Buy
83,147
+62,766
+308% +$2.25M 0.02% 417
2020
Q2
$493K Sell
20,381
-1,905
-9% -$46.1K ﹤0.01% 1795
2020
Q1
$390K Buy
22,286
+7,086
+47% +$124K ﹤0.01% 1686
2019
Q4
$265K Sell
15,200
-19,910
-57% -$347K ﹤0.01% 1965
2019
Q3
$538K Buy
35,110
+25,668
+272% +$393K ﹤0.01% 1598
2019
Q2
$196K Buy
9,442
+467
+5% +$9.69K ﹤0.01% 2086
2019
Q1
$208K Buy
+8,975
New +$208K ﹤0.01% 2219